PharmaVentures acts as advisor to Intocell on their ongoing collaboration agreement with Cellectar
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
PharmaVentures acts as independent commercial expert with respect to Spectral MD s IPO listing this month on London s AIM
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
(1)
OXFORD, England, March 3, 2021 /PRNewswire/ PharmaVentures is pleased to announce it acted as exclusive M&A advisor on the sale of the ERA Consulting Group to PharmaLex GmbH.
ERA Consulting is a leading strategic product development and regulatory consulting group serving the global biopharmaceutical industry. For nearly 30 years, the company has provided services at all stages of product development, from conception to registration and beyond, and has enjoyed considerable success completing projects on hundreds of products for a wide range of top international clients. This transaction highlights our track record in supporting the sale of specialist pharmaceutical clinical services companies in the pharmaceutical industry, said Dr Fintan Walton, CEO and Founder of PharmaVentures. Our decades of experience in M&A, together with our detailed knowledge of the pharmaceutical clinical services industry which includes the global regulatory affairs outsourcing market, enabled u